ABCL635

AbCellera Biologics Inc. · Phase 1 active Biologic

At a glance

Generic name	ABCL635
Sponsor	AbCellera Biologics Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ABCL635 CI brief — competitive landscape report
ABCL635 updates RSS · CI watch RSS
AbCellera Biologics Inc. portfolio CI